Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Reynolds

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Artificial Life|April 29, 2025
Camouflage From Coevolution of Predator and PreyCraig Reynolds
Artificial Life|March 5, 2011
Interactive evolution of camouflageCraig Reynolds
Cancer|January 27, 2005
An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphomaNicholas Di Bella, Craig Reynolds, David Faragher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 28, 2015
A Retinotopic Basis for the Division of High-Level Scene Processing between Lateral and Ventral Human Occipitotemporal CortexEdward Harry Silson, Annie Wai-Yiu Chan, Richard Craig Reynolds, et al.
Journal of Clinical Medicine|May 31, 2018
Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational StudyCraig Reynolds, Elizabeth T Masters, Jenny Black-Shinn, et al.
Clinical Lung Cancer|December 6, 2011
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancerDennis L Carter, David Garfield, James Hathorn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2009
Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancerCraig Reynolds, David Barrera, Robert Jotte, et al.
Investigational New Drugs|June 14, 2013
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trialCraig Reynolds, Alexander I Spira, Larry Gluck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapyRobert Jotte, Paul Conkling, Craig Reynolds, et al.
Investigational New Drugs|September 17, 2011
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemiaCraig Reynolds, Nicholas Di Bella, Roger M Lyons, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Artificial Life|April 29, 2025
Camouflage From Coevolution of Predator and PreyCraig Reynolds
Artificial Life|March 5, 2011
Interactive evolution of camouflageCraig Reynolds
Cancer|January 27, 2005
An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphomaNicholas Di Bella, Craig Reynolds, David Faragher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 28, 2015
A Retinotopic Basis for the Division of High-Level Scene Processing between Lateral and Ventral Human Occipitotemporal CortexEdward Harry Silson, Annie Wai-Yiu Chan, Richard Craig Reynolds, et al.
Journal of Clinical Medicine|May 31, 2018
Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational StudyCraig Reynolds, Elizabeth T Masters, Jenny Black-Shinn, et al.
Clinical Lung Cancer|December 6, 2011
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancerDennis L Carter, David Garfield, James Hathorn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2009
Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancerCraig Reynolds, David Barrera, Robert Jotte, et al.
Investigational New Drugs|June 14, 2013
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trialCraig Reynolds, Alexander I Spira, Larry Gluck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapyRobert Jotte, Paul Conkling, Craig Reynolds, et al.
Investigational New Drugs|September 17, 2011
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemiaCraig Reynolds, Nicholas Di Bella, Roger M Lyons, et al.
Pageof 2